{"preliminary_commentary":{"by_channel":{"x_thread":13,"youtube":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT06367972\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"name":"NCT06367972","nct_id":"NCT06367972","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=nct06367972. The price is an estimate of verified statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"Participants are assigned to Group 1, participants will be treated with next-line systemic therapy. The specific next-line systemic therapy will be determined by your doctor.\n\n\\- If progression occurs (the disease gets worse), participants may cross over to Group 2 and receive LCT.","label":"NLST Arm","type":"EXPERIMENTAL"},{"description":"Participants are assigned to Group 2, participants will be treated with LCT and then continue on same systemic therapy participants have been receiving followed by the next line systemic of therapy (if applicable). The specific treatments will be determined by your doctor.","label":"LCT Arm","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2030-10-10","type":"ESTIMATED"},"conditions":["OligoProgressive Metastatic Disease"],"enrollment":{"count":400,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Local Consolidation Therapy","otherNames":["LCT"],"type":"PROCEDURE"},{"name":"Next-line Systemic Therapy","otherNames":["NLST"],"type":"PROCEDURE"}],"last_update":"2026-06-11","lead_sponsor":"M.D. Anderson Cancer Center","official_title":"A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)","overall_status":"RECRUITING","phases":["PHASE2","PHASE3"],"primary_completion_date":{"date":"2028-10-10","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Safety and adverse events (AEs)","timeFrame":"Through study completion; an average of 1 year."}],"references":[],"start_date":{"date":"2024-06-06","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)","url":"https://clinicaltrials.gov/study/NCT06367972"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/nct06367972"}